Redhill Biopharma (RDHL) Institutional Ownership $1.61 -0.02 (-1.23%) Closing price 04:00 PM EasternExtended Trading$1.63 +0.02 (+1.24%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Redhill Biopharma (NASDAQ:RDHL)CurrentInstitutional OwnershipPercentage7.20%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.60KNumber ofInstitutional Sellers(last 12 months)0 Get RDHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Redhill Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RDHL Institutional Buying and Selling by Quarter Redhill Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/3/2025GAMMA Investing LLC5,089$32K0.0%N/A0.397% 5/14/2024Gagnon Securities LLC118,360$63K0.0%+32.1%0.398% 11/15/2023Sabby Management LLC635,006$324K0.2%N/A5.736% 11/15/2023Armistice Capital LLC722,894$369K0.0%N/A6.530% 8/7/2023Cowen AND Company LLC288,000$346K0.0%N/A7.328% 2/7/2023Gagnon Securities LLC331,858$47K0.0%-14.0%0.518% 2/7/2023CLARET ASSET MANAGEMENT Corp228,430$32K0.0%+139.4%0.357% 11/7/2022Virtu Financial LLC62,182$31K0.0%+44.8%0.118% 7/11/2022ARK Investment Management LLC1,045,023$1.17M0.0%+21.3%1.984% 5/16/2022Disciplined Growth Investors Inc. MN1,950,002$4.91M0.1%+0.7%3.701% Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 5/9/2022Gagnon Securities LLC367,346$926K0.2%+15.4%0.697% 4/19/2022ARK Investment Management LLC861,798$2.17M0.0%N/A1.636% 2/15/2022Disciplined Growth Investors Inc. MN1,935,589$4.99M0.1%-2.1%3.694% 2/14/2022GSA Capital Partners LLP218,338$563K0.1%+108.4%0.417% 2/10/2022Candriam Luxembourg S.C.A.71,267$184K0.0%-13.6%0.136% 2/10/2022HighTower Advisors LLC12,300$32K0.0%N/A0.023% 2/8/2022Gagnon Securities LLC318,323$821K0.1%-18.8%0.607% 2/7/2022Ibex Investors LLC261,616$675K0.2%-63.4%0.499% 2/7/2022CLARET ASSET MANAGEMENT Corp95,430$246K0.0%+52.1%0.182% 2/3/2022Cambridge Investment Research Advisors Inc.27,632$71K0.0%N/A0.053% 1/24/2022National Bank of Canada FI43,000$111K0.0%N/A0.082% 12/2/2021CLARET ASSET MANAGEMENT Corp62,730$287K0.0%+14.1%0.120% 11/15/2021Ancora Advisors LLC37,500$172K0.0%N/A0.080% 11/15/2021Eaton Vance Management38,417$176K0.0%N/A0.082% 11/15/2021GSA Capital Partners LLP104,754$480K0.0%+28.1%0.224% 11/12/2021Gagnon Securities LLC392,245$1.80M0.3%+14.5%0.841% 11/10/2021Goldman Sachs Group Inc.76,368$350K0.0%+36.6%0.164% 11/9/2021BlackRock Inc.312,139$1.43M0.0%+8.2%0.669% 11/5/2021Ibex Investors LLC715,293$3.28M0.7%-26.3%1.533% 11/5/2021Advisor Group Holdings Inc.24,101$110K0.0%+288.7%0.052% 11/5/2021ARS Investment Partners LLC52,495$240K0.0%-41.9%0.112% 11/4/2021Woodward Diversified Capital LLC17,089$78K0.0%-56.0%0.037% 10/29/2021Commonwealth Equity Services LLC11,687$53K0.0%N/A0.025% 10/27/2021Ingalls & Snyder LLC29,000$133K0.0%+52.6%0.062% 10/27/2021Phoenix Holdings Ltd.16,578$75K0.0%N/A0.036% 10/19/2021Henry James International Management Inc.75,078$344K0.1%+17.2%0.161% 10/14/2021Capital Asset Advisory Services LLC28,888$132K0.0%N/A0.062% 9/3/2021Parametric Portfolio Associates LLC45,856$315K0.0%+6.5%0.098% 8/16/2021Disciplined Growth Investors Inc. MN1,976,476$13.60M0.3%+8.1%4.260% 8/16/2021State Street Corp109,594$754K0.0%+16.2%0.236% 8/16/2021Goldman Sachs Group Inc.55,915$385K0.0%-4.6%0.121% 8/13/2021Renaissance Technologies LLC19,879$137K0.0%N/A0.043% 8/13/2021Jump Financial LLC14,700$101K0.0%N/A0.032% 8/13/2021Geode Capital Management LLC27,229$187K0.0%+10.3%0.059% 8/11/2021BlackRock Inc.288,363$1.98M0.0%-18.9%0.622% 8/5/2021Ibex Investors LLC970,936$6.68M2.3%-56.2%2.093% (Data available from 1/1/2016 forward) RDHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RDHL shares? During the previous two years, the following institutional investors and hedge funds held shares of Redhill Biopharma shares: Armistice Capital LLC ($369K), Sabby Management LLC ($324K), and Gagnon Securities LLC ($63K), GAMMA Investing LLC ($32K).Learn more on Redhill Biopharma's institutional investors. What percentage of Redhill Biopharma's stock is owned by institutional investors? 7.20% of Redhill Biopharma's stock is owned by institutional investors. Learn more on RDHL's institutional investor holdings. Which institutional investors have been buying Redhill Biopharma's stock? The following institutional investors have purchased Redhill Biopharma's stock in the last 24 months: Armistice Capital LLC ($722.89K), Sabby Management LLC ($635.01K), Gagnon Securities LLC ($28.77K), and GAMMA Investing LLC ($5.09K). How much institutional buying is happening at Redhill Biopharma? Institutional investors have bought a total of 5,089 shares in the last 24 months. This purchase volume represents approximately $31.60K in transactions. Related Companies Passage Bio Institutional Ownership MIRA Pharmaceuticals Institutional Ownership Allarity Therapeutics Institutional Ownership Citius Pharmaceuticals Institutional Ownership NanoViricides Institutional Ownership Moleculin Biotech Institutional Ownership Rallybio Institutional Ownership Aytu BioPharma Institutional Ownership Synergy CHC Institutional Ownership FibroBiologics Institutional Ownership This page (NASDAQ:RDHL) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redhill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Redhill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
